Integration of genomic analysis and transcript expression of ABCC8 and KCNJ11 in focal form of congenital hyperinsulinism

• Published in: Frontiers in endocrinology (Lausanne) 2022-10, Vol.13, p.1015244-1015244
• Main Authors: Wieland, Ilse, Schanze, Ina, Felgendreher, Ina Marianti, Barthlen, Winfried, Vogelgesang, Silke, Mohnike, Klaus, Zenker, Martin
• Format: Article
• Language: English
• Subjects: ABCC8; Achaete-scute complex homolog 2; Basic Helix-Loop-Helix Transcription Factors - genetics; CHI; Congenital Hyperinsulinism - genetics; Congenital Hyperinsulinism - pathology; Endocrinology; Genomics; Humans; KCNJ11; Loss of Heterozygosity; Potassium Channels, Inwardly Rectifying - genetics; Sulfonylurea Receptors - genetics; Uniparental Disomy - genetics; UPD 11p
• ISSN: 1664-2392; 1664-2392
• DOI: 10.3389/fendo.2022.1015244

The focal form of CHI is caused by an autosomal recessive pathogenic variant affecting the paternal homologue of genes or and a second somatic event specifically occurring in the affected islet of Langerhans. The approach of this study was to integrate the genetic changes occurring in pancreatic focal lesions of CHI at the genomic and transcriptional level. Patients receiving therapeutic surgery and with proven or pathogenic variants were selected and analyzed for loss of heterozygosity (LOH), changes in copy number and uniparental disomy (UPD) on the short am of chromosome 11 by molecular microarray analysis and methylation-specific MLPA. Gene expression was analyzed by RT-PCR and Massive Analysis of cDNA Ends (MACE). Both genes, and , are located in proximity to the Beckwith-Wiedemann (BWS) imprinting control region on chromosome 11p15. Somatic paternal uniparental isodisomy (UPD) at chromosome 11p was identified as second genetic event in focal lesions resulting in LOH and monoallelic expression of the mutated alleles. Of five patients with samples available for microarray analysis, the breakpoints of UPD on chromosome 11p were different. Samples of two patients were analyzed further for changes in gene expression. Profound downregulation of growth suppressing genes and was detected in focal lesions whereas growth promoting gene and pancreatic transcription factors of the endocrine cell lineage were upregulated. Paternal UPD on the short arm of chromosome 11 appears to be the major second genetic event specifically within focal lesions of CHI but no common breakpoint for UDP can be delineated. We show for the first time upregulation of growth promoting (achaete-scute homolog 2) suggestive of a driving factor in postnatal focal expansion in addition to downregulation of growth suppressing genes and .